RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,728,000 | -16.3% | 1,600,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,064,000 | -2.3% | 1,600,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $2,112,000 | -12.0% | 1,600,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,400,000 | +26.8% | 1,600,000 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $1,892,000 | +4.4% | 1,600,000 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,812,000 | -62.2% | 1,603,252 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,794,000 | +12.8% | 1,603,252 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,249,000 | -27.0% | 1,603,252 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $5,820,000 | -16.4% | 1,603,252 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $6,958,000 | +26.9% | 1,603,252 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $5,483,000 | -2.4% | 1,603,252 | -0.1% | 0.01% | 0.0% |
| Q4 2020 | $5,617,000 | +45.8% | 1,604,794 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $3,852,000 | +31.2% | 1,604,794 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $2,937,000 | +17.7% | 1,604,794 | +0.3% | 0.01% | 0.0% |
| Q1 2020 | $2,496,000 | -27.1% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $3,424,000 | +14.4% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $2,992,000 | -76.1% | 1,600,000 | -66.7% | 0.01% | -28.6% |
| Q2 2019 | $12,528,000 | +204.7% | 4,800,000 | +200.0% | 0.01% | 0.0% |
| Q1 2019 | $4,112,000 | +11.7% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $3,680,000 | -28.3% | 1,600,000 | 0.0% | 0.01% | -12.5% |
| Q3 2018 | $5,136,000 | +13.4% | 1,600,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $4,528,000 | +42.1% | 1,600,000 | +77.8% | 0.01% | +33.3% |
| Q1 2018 | $3,186,000 | +4.7% | 900,000 | +14.8% | 0.01% | +20.0% |
| Q4 2017 | $3,042,000 | +63.1% | 784,088 | +6.8% | 0.01% | +66.7% |
| Q3 2017 | $1,865,000 | +7.6% | 734,088 | +15.6% | 0.00% | 0.0% |
| Q2 2017 | $1,734,000 | -1.6% | 635,000 | +19.3% | 0.00% | 0.0% |
| Q1 2017 | $1,762,000 | – | 532,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |